These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3573871)

  • 1. [The low number of reported adverse effects after vaccination against measles, mumps, rubella].
    Taranger J; Wiholm BE
    Lakartidningen; 1987 Mar; 84(12):948-50. PubMed ID: 3573871
    [No Abstract]   [Full Text] [Related]  

  • 2. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland.
    Pebody RG; Paunio M; Ruutu P
    BMJ; 1998 Jun; 316(7146):1745-6. PubMed ID: 9652932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles, mumps, and rubella vaccine.
    BMJ; 1988 Sep; 297(6651):780-1. PubMed ID: 3142548
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
    Isozaki M; Kuno-Sakai H; Hoshi N; Takesue R; Takakura I; Kimura M; Hikino M; Mitsuda M
    Tokai J Exp Clin Med; 1982 Sep; 7(5):547-50. PubMed ID: 7182947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
    Miller E; Waight P
    BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.
    Vlacha V; Forman EN; Miron D; Peter G
    Pediatrics; 1996 May; 97(5):738-9. PubMed ID: 8628619
    [No Abstract]   [Full Text] [Related]  

  • 10. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

  • 11. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/headache?".
    Passwell JH
    Isr Med Assoc J; 1999 Nov; 1(3):176-7. PubMed ID: 10731330
    [No Abstract]   [Full Text] [Related]  

  • 12. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolytic and uremic syndrome after measles, mumps and rubella vaccination. Fortuitous association?].
    Tsimaratos M; Le Menestrel S; Daniel L; Roquelaure B; Almhana T; de Montléon JV; Paut O; Picon G; Casanova P; Sarles J
    Arch Pediatr; 1997 Dec; 4(12):1261-2. PubMed ID: 9538434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Jun; 61(4-5):170-1. PubMed ID: 8361148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reactions after MMR vaccination].
    Kaaber K; Samuelsson IS; Larsen SO
    Ugeskr Laeger; 1990 Jun; 152(23):1672-6. PubMed ID: 2363211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polyradiculitis associated with vaccination against measles, parotitis and rubella].
    Lakartidningen; 1984 Apr; 81(16):1636-7. PubMed ID: 6717184
    [No Abstract]   [Full Text] [Related]  

  • 17. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 19. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
    Amin J; Wong M
    Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.